Search results
Dr. Yiping Yang is a Oncologist in Columbus, OH. Find Dr. Yang's phone number, address, insurance information, hospital affiliations and more.
- Columbus, OH
- (614) 714-4945
- DAVID E. COHN, MD, MBA
- MELISSA HALL
- WILLIAM “SKIP” HIDLAY
- BECCA PETERSON, PhD
- PETER SHIELDS, MD
- NANCY SINGLE, PhD
- THE OSUCCC – JAMES INVITES YOU TO JOIN OUR ONLINE COMMUNITY
- Feng Hong, MD – Assistant Professor, Division of Medical Oncology
- Xiaopei Huang, PhD - Associate Professor, Division of Hematology
- Chan-Wang “Jerry” Lio, PhD – Assistant Professor, Department of Microbial Infection and Immunity
- Brian Searle, PhD – Assistant Professor, Department of Biomedical Informatics
- Joyce Wu, PhD – Professor, Department of Internal Medicine, Division of Rheumatology
- Linghua Zheng, PhD – Assistant Professor, Division of Medical Oncology
- Stanley Huang, PhD – Associate Professor, Department of Microbial Infection and Immunity
- SCIENTIFIC ACCOMPLISHMENTS
- Sex bias in cancer immunotherapy
- SUSD2: A new potential cancer immunotherapy target
- SIIREN/STOP-COVID teams awarded a U54 supplement
- Restoring the ability of exhausted T cells to respond to immune checkpoint blockade
- Lieping Chen, MD, PhD
- Susan Kaech, PhD
- Postdoc, Residents, Fellows
- Graduate Students
- Undergraduates, Laboratory Staf
- Qin Ma, PhD
- Jordan Krull, PhD
- Dongjun Chung, PhD
- Brian Searle, PhD
- Anjun Ma, PhD
- Yuzhou Chang
- Juan Xie, MS
- The PIIO Immune Monitoring Discovery Platform, Immuno-Oncology Network (IMDP-ION)
- cancer.osu.edu/PIIO
- cancer.osu.edu
- PELOTONIA.ORG/ REGISTER
Interim CEO and Chief Medical Oficer James Cancer Hospital and Solove Research Institute
Associate Vice President, Growth Marketing and Reputation Strategy
Vice President, Chief Communications and Marketing Oficer
Senior Director, Strategic Initiatives RAPHAEL E. POLLOCK, MD, PhD, FACS Director, The Ohio State University Comprehensive Cancer Center
Deputy Director, The Ohio State University Comprehensive Cancer Center
Director, Clinical Research Operations CORRIN STEINHAUER, DNP, RN, NEA-BC, CPPS Chief Nursing Oficer, James Cancer Hospital and Solove Research Institute
cancer.osu.edu/blog facebook.com/OSUCCCJames twitter.com/OSUCCC_James youtube.com/OSUTheJames cancer.osu.edu/linkedin soundcloud.com/thejamescancerfreeworld The PIIO aims to become an institute of choice for IO talent. To accomplish this, it is recruiting a diverse team of top-tier talent, developing programs to train the next generation of IO rese...
Dr. Hong is developing a new class of therapeutics for cancer based on the rational design of unfolded protein response (UPR) inhibitors against the pathological ER stress in cancer and cancer immunology.
Dr. Huang is interested in the tumor microenvironment and the role that tumor-associated neutrophils play in cancer development and progression.
Dr. Lio is interested in the role of T cells in TET-deficient B-cell lymphoma.
Dr. Seale is identifying tumor-specific splice junctions as potential immunotherapeutic targets in glioblastoma.
Dr. Wu’s research interests include microbiomes, immune regulation, auto immunity and cancer.
Dr. Zheng is interested in identifying novel signaling pathways mediated by cell surface proteins that regulate T-cell homeostasis, activation and tolerance in physiological and pathological conditions.
Dr. Huang seeks to understand the interplay between cellular signaling and metabolic regulation that dictates immune cell activation during inflammation.
Marcos de Lima, MD Sumithira Vasu, MBBS Lynn O’Donnell, PhD Lapo Alinari, MD, PhD
Sex bias exists in the development and progression of nonreproductive organ cancers, but the underlying mechanisms are enigmatic. Led by Dr. Zihai Li, this research team has discovered a role for CD8+ T cell-dependent antitumor immunity in mediating sex diferences in tumor aggressiveness, which is driven by the gonadal androgen but not sex chromoso...
While immune checkpoint blockade (ICB) is a groundbreaking cancer treatment that has revolutionized the way many patients are treated, it remains an uncommon therapy from which only a small percentage of patients experience long-term clinical benefits. A decline in immune function prevents many patients with cancer from achieving durable clinical r...
Cancer patients, especially those receiving active immune suppressive or altering therapy, represent a highly vulnerable population with increased risk of SARS-CoV2 breakthrough infection despite mRNA vaccination and boosters. Researchers in the PIIO hypothesized that variability in the durability and memory of T-cell and antibody responses followi...
T cell dysfunction is a common cause of immune system failure, which in turn limits the efectiveness of immunotherapies. Additionally, epigenetic programming within dysfunctional CD8+ T cells impedes their response to ICB therapies. To clarify which upstream signals drive acquisition of dysfunctional epigenetic programs and to determine whether the...
United Technologies Corporation Professor in Cancer Research; Professor of Immunobiology, Dermatology and Medical Oncology; Yale School of Medicine
Professor and Director, NOMIS Center for Immunobiology and Microbial Pathogenesis; Salk Institute for Biological Studies Xiaole “Shirley” Liu, PhD
First Place: Luciano Mazzoccoli, PhD – Mentor, Bei Liu, MD, MPH Second Place: Dr. No-Joon Song, PhD – Mentor, Zihai Li, MD, PhD Third Place: Joseph Azar, MD – Mentor, Mark Rubinstein, PhD
First Place: Yinchong Wang – Mentor, Anna Vilgelm, MD, PhD Second Place: Jianying Li – Mentors, Gang Xin, PhD, and Qin Ma, PhD Third Place: Jessica Wedig – Mentor, Thomas Mace, PhD
First Place: Pete Jordanides – Mentor, Steve Oghumu, PhD Second Place: Nyelia Williams – Mentor, Daniel Spakowicz, PhD Third Place: Mikayla Bull – Mentor, Susheela Tridandapani, PhD
Core leader Associate Professor Department of Biomedical Informatics
Postdoc Fellow Department of Biomedical Informatics
JOIN THE PELOTONIA COMMUNITY AS A RIDER, VOLUNTEER, OR CHALLENGER!
JOIN THE PELOTONIA COMMUNITY AS A RIDER, VOLUNTEER, OR CHALLENGER!
JOIN THE PELOTONIA COMMUNITY AS A RIDER, VOLUNTEER, OR CHALLENGER!
JOIN THE PELOTONIA COMMUNITY AS A RIDER, VOLUNTEER, OR CHALLENGER!
JOIN THE PELOTONIA COMMUNITY AS A RIDER, VOLUNTEER, OR CHALLENGER!
JOIN THE PELOTONIA COMMUNITY AS A RIDER, VOLUNTEER, OR CHALLENGER!
JOIN THE PELOTONIA COMMUNITY AS A RIDER, VOLUNTEER, OR CHALLENGER!
JOIN THE PELOTONIA COMMUNITY AS A RIDER, VOLUNTEER, OR CHALLENGER!
JOIN THE PELOTONIA COMMUNITY AS A RIDER, VOLUNTEER, OR CHALLENGER!
Netflix confirmed the production of the upcoming K-drama Everything Will Come True which will be penned by renowned writer Kim Eun Sook.
460 W 12th Avenue. 508 Biomedical Research Tower. Columbus, OH 43210. Phone+1 614-685-0638. Is this information wrong? Education & Training. Johns Hopkins University Fellowship, Hematology and Medical Oncology, 1999 - 2002. University of Pennsylvania Health System Residency, Internal Medicine, 1996 - 1999. Zhejiang Medical University Class of 1985.
- 460 W 12th Avenue 508 Biomedical Research Tower, Columbus, 43210, OH
Yiping Yang's 95 research works with 5,248 citations and 8,247 reads, including: A novel CAR-T cell product targeting CD74 is an effective therapeutic approach in preclinical mantle cell...
Clinical Assistant Professor of Neurological Surgery. Accepting new patients. Insurances We Accept. 855-255-0550. About Me. I am a neurosurgeon who specializes in treating patients with epilepsy and movement disorders, including Parkinson’s disease, essential tremor and dystonia.
Xiaoxi Yang, MD. Psychiatric Hospitalist. Child And Adolescent Psychiatry. Psychiatry. UnityPoint Provider. Hospital Affiliations: St. Luke's Hospital. Gender: Male. About Xiaoxi Yang, MD. Education. Focus Areas. Medical School. University of Iowa Carver College of Medicine: MD. Undergraduate Education. Grinnell College. Biography.
